SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001558370-23-013301
Filing Date
2023-08-04
Accepted
2023-08-04 07:30:36
Documents
62
Period of Report
2023-06-30

Document Format Files

Seq Description Document Type Size
1 6-K aciu-20230630x6k.htm   iXBRL 6-K 91825
2 EX-99.1 aciu-20230630xex99d1.htm   iXBRL EX-99.1 781259
3 EX-99.2 aciu-20230630xex99d2.htm EX-99.2 261653
4 EX-99.3 aciu-20230630xex99d3.htm EX-99.3 189674
5 GRAPHIC aciu-20230630xex99d3001.jpg GRAPHIC 3076
  Complete submission text file 0001558370-23-013301.txt   4461635

Data Files

Seq Description Document Type Size
6 EX-101.SCH aciu-20230630.xsd EX-101.SCH 42642
7 EX-101.CAL aciu-20230630_cal.xml EX-101.CAL 49409
8 EX-101.DEF aciu-20230630_def.xml EX-101.DEF 94840
9 EX-101.LAB aciu-20230630_lab.xml EX-101.LAB 284015
10 EX-101.PRE aciu-20230630_pre.xml EX-101.PRE 205830
56 EXTRACTED XBRL INSTANCE DOCUMENT aciu-20230630x6k_htm.xml XML 735649
Mailing Address EPFL INNOVATION PARK, BUILDING B 1015 LAUSANNE V8 00000
Business Address EPFL INNOVATION PARK, BUILDING B 1015 LAUSANNE V8 00000 41 21 345 91 21
AC Immune SA (Filer) CIK: 0001651625 (see all company filings)

IRS No.: 000000000 | State of Incorp.: V8 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-37891 | Film No.: 231142162
SIC: 2834 Pharmaceutical Preparations